Curemark
PrivateLast Round
Early Funding
Mar 27, 2023
Total Funding Raised
$80.59M
Company Overview
Curemark is a biopharmaceutical company developing novel therapies for the treatment of serious unmet needs in neuro-developmental and neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curemark Comparables
Compare Curemark with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yamo Pharmaceuticals | 83% | |
| Confluence Pharmaceuticals | 81% | |
| PaxMedica, Inc. | 79% | |
Curemark Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 27, 2023 | ||||
| Private Placement | Jun 2, 2021 | ||||
| Early Funding | Sep 11, 2019 | ||||
| Private Placement | Feb 20, 2018 | ||||
| VC Round | Mar 20, 2017 | ||||
Private Equity | Jul 13, 2015 |
Curemark Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deutsch Capital | Private Placement |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 14, 2014
Raised $19M in early funding.
- Oct 8, 2013
$19M raised in a private placement round.
Curemark Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Curemark's valuation, stock price, and market status.